-
1
Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Published 2025“…Objective<p>This study endeavors to develop and validate an integrated biomarker signature (IBS) grounded in serum carbohydrate antigen 72-4 (CA72-4), vascular endothelial growth factor-C (VEGF-C), and the pepsinogen I/II ratio (PGI/PGII). …”
-
2
Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Published 2025“…Objective<p>This study endeavors to develop and validate an integrated biomarker signature (IBS) grounded in serum carbohydrate antigen 72-4 (CA72-4), vascular endothelial growth factor-C (VEGF-C), and the pepsinogen I/II ratio (PGI/PGII). …”
-
3
Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Published 2025“…Objective<p>This study endeavors to develop and validate an integrated biomarker signature (IBS) grounded in serum carbohydrate antigen 72-4 (CA72-4), vascular endothelial growth factor-C (VEGF-C), and the pepsinogen I/II ratio (PGI/PGII). …”